1. Emerging Perspectives on DNA Double-strand Breaks in Neurodegenerative Diseases
- Author
-
Ke Cui, Dan Liu, Ling-Qiang Zhu, Ding-Qi Wang, and Ling-Shuang Zhu
- Subjects
0301 basic medicine ,amyotrophic lateral sclerosis ,Disease ,Biology ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Huntington's disease ,huntington’s disease ,medicine ,Animals ,Humans ,DNA double-strand breaks ,DNA Breaks, Double-Stranded ,neurodegenerative diseases ,Pharmacology (medical) ,Amyotrophic lateral sclerosis ,Pharmacology ,histone modifications ,apoptosis ,DNA replication ,alzheimer’s disease ,General Medicine ,medicine.disease ,Psychiatry and Mental health ,030104 developmental biology ,Histone ,Neurology ,chemistry ,Ataxia-telangiectasia ,Cancer research ,biology.protein ,Neurology (clinical) ,Homologous recombination ,030217 neurology & neurosurgery ,DNA - Abstract
DNA double-strand breaks (DSBs) are common events that were recognized as one of the most toxic lesions in eukaryotic cells. DSBs are widely involved in many physiological processes such as V(D)J recombination, meiotic recombination, DNA replication and transcription. Deregulation of DSBs has been reported in multiple diseases in human beings, such as the neurodegenerative diseases, with which the underlying mechanisms are needed to be illustrated. Here, we reviewed the recent insights into the dysfunction of DSB formation and repair, contributing to the pathogenesis of neurodegenerative disorders including Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), Huntington’s disease (HD) and ataxia telangiectasia (A-T).
- Published
- 2019
- Full Text
- View/download PDF